Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 10;32(5):280.
doi: 10.1007/s00520-024-08462-x.

2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients

Samantha K F Kennedy  1 , Shannon Goodall  2 , Shing Fung Lee  3   4 , Carlo DeAngelis  5 , Allison Jocko  6 , Flay Charbonneau  5 , Katie Wang  5 , Mark Pasetka  5 , Yoo-Joung Ko  7 , Henry C Y Wong  8 , Adrian Wai Chan  5 , Thenugaa Rajeswaran  5 , Milena Gojsevic  5 , Edward Chow  5 , Richard J Gralla  9 , Terry L Ng  10 , Katarzyna J Jerzak  5
Affiliations
Review

2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients

Samantha K F Kennedy et al. Support Care Cancer. .

Abstract

Chemotherapy-induced nausea and vomiting (CINV) is a common toxicity that may impair the quality of life of patients with various malignancies ranging from early to end stages. In light of frequent changes to the guidelines for optimal management of CINV, we undertook this narrative review to compare the most recent guidelines published by ASCO (2020), NCCN (2023), MASCC/ESMO (2023), and CCO (2019). The processes undertaken by each organization to evaluate existing literature were also described. Although ASCO, NCCN, MASCC/ESMO, and CCO guidelines for the treatment and prevention of CINV share many fundamental similarities, the literature surrounding low and minimal emetic risk regimens is lacking. Current data regarding adherence to these guidelines is poor and warrants further investigation to improve care.

Keywords: Antiemetic; Chemotherapy-induced nausea and vomiting; Guidelines; Prophylaxis.

PubMed Disclaimer

References

    1. Coates A, Abraham S, Kaye SB et al (1983) On the receiving end—patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19:203–208 - DOI - PubMed
    1. Vardy JL, Liew A, Warby A et al (2022) On the receiving end: have patient perceptions of the side-effects of cancer chemotherapy changed since the twentieth century? Support Care Cancer 30:3503–3512 - DOI - PubMed - PMC
    1. Kuchuk I, Bouganim N, Beusterien K et al (2013) Patient perceptions about potential side effects and benefits from chemotherapy agents. J Clin Oncol 31:6595–6595 - DOI
    1. Matzka M, Köck-Hódi S, Jahn P et al (2018) Relationship among symptom clusters, quality of life, and treatment-specific optimism in patients with cancer. Support Care Cancer 26:2685–2693 - DOI - PubMed - PMC
    1. Grunberg SM, Warr D, Gralla RJ et al (2011) Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—state of the art. Support Care Cancer 19:S43–S47 - DOI - PubMed

LinkOut - more resources